Experts: The world needs more than just mRNA vaccines

Lots of different vaccine platforms for a range of diseases will be needed in the future because the hyped-up mRNA technology has clear limitations.

If you believe in a future when vaccines are solely based on mRNA technology, you might want to think again.

A number of diseases are far too complicated for mRNA, and it must be remembered that companies like Novavax have produced a highly-effective corona vaccine using a completely different technology than Moderna and BioNTech/Pfizer.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Pfizer upgrades guidance for sales of covid-19 vaccine

The US pharmaceutical company Pfizer now predicts sales of its coronavirus vaccines will total USD 33.5bn this year. The previous estimate was UDS 26bn. Meanwhile, the company has revealed the guidance for its annual revenue.

Further reading

Related articles

Trial banner

Latest news

See all jobs